100 related articles for article (PubMed ID: 27741429)
1. Altered CSF cytokine network in amyotrophic lateral sclerosis patients: A pathway-based statistical analysis.
Martínez HR; Escamilla-Ocañas CE; Tenorio-Pedraza JM; Gómez-Almaguer D; Jaime-Perez JC; Olguín-Ramírez LA; Salazar-Marioni S; González-Garza MT
Cytokine; 2017 Feb; 90():1-5. PubMed ID: 27741429
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
3. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis.
Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Moreno-Cuevas J; García Sarreón MA
Neurologia (Engl Ed); 2020 Apr; 35(3):165-169. PubMed ID: 29029824
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.
Drannik A; Martin J; Peterson R; Ma X; Jiang F; Turnbull J
PLoS One; 2017; 12(2):e0171668. PubMed ID: 28170441
[TBL] [Abstract][Full Text] [Related]
5. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
6. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Mishra PS; Dhull DK; Nalini A; Vijayalakshmi K; Sathyaprabha TN; Alladi PA; Raju TR
J Neuroinflammation; 2016 Aug; 13(1):212. PubMed ID: 27578023
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
8. CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis.
Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Tenorio-Pedraza JM; Hernández-Torre M
Acta Neurol Belg; 2017 Dec; 117(4):879-883. PubMed ID: 28550440
[TBL] [Abstract][Full Text] [Related]
9. ALS: cytokine profile in cerebrospinal fluid T-cell clones.
Holmøy T; Roos PM; Kvale EØ
Amyotroph Lateral Scler; 2006 Sep; 7(3):183-6. PubMed ID: 16963408
[TBL] [Abstract][Full Text] [Related]
10. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
11. In Amyotrophic Lateral Sclerosis Blood Cytokines Are Altered, but Do Not Correlate with Changes in Brain Topology.
Polverino A; Rucco R; Stillitano I; Bonavita S; Grimaldi M; Minino R; Pesoli M; Trojsi F; D'Ursi AM; Sorrentino G; Sorrentino P
Brain Connect; 2020 Oct; 10(8):411-421. PubMed ID: 32731760
[No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
13. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.
Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y
J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
15. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
[TBL] [Abstract][Full Text] [Related]
16. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
19. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
Iłecka J
J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
